Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ARGS
Tag: NASDAQ:ARGS
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Bankruptcy or Receivership
ME Staff 8-k
-
December 3, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Notice of Delisting or...
ME Staff 8-k
-
April 25, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
April 2, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Other Events
ME Staff 8-k
-
March 8, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Other Events
ME Staff 8-k
-
February 16, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
February 6, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Other Events
ME Staff 8-k
-
January 8, 2018
0
Insider Trading Activity Argos Therapeutics Inc (NASDAQ:ARGS) – VP Sold 59,072...
ME Staff
-
January 5, 2018
0
Insider Trading Activity Argos Therapeutics Inc (NASDAQ:ARGS) – CEO Sold 114,702...
ME Staff
-
January 5, 2018
0
Argos Therapeutics, Inc. (NASDAQ:ARGS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
November 28, 2017
0
1
2
3
Page 1 of 3
